Scientific & Regulatory Consulting•Toxicology & Product Safety
Request basket0
PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Diphenoxylate→

Diphenoxylate PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
915-30-0
Molecular formula
C30H32N2O2
Molecular weight
452.6 g/mol
Drug class
Peripheral opioid antidiarrhoealmu-opioid receptor agonist
Mechanism of action
Activates opioid receptors in the intestinal wall, reducing propulsive peristalsis and prolonging intestinal transit time, which increases fluid and electrolyte absorption. It is commonly combined with atropine to discourage misuse.
Indications / reported uses
  • Adjunctive treatment of acute nonspecific diarrhoea in adults and children aged 13 years and older under the US product label, with fluid and electrolyte replacement as needed; not for bloody diarrhoea, invasive enteritis or toxin-mediated diarrhoea without evaluation

Sources: US DailyMed — Diphenoxylate/atropine · NLM MeSH — Diphenoxylate · FDA product information

View request basketPrefer email? [email protected]
PDE / ADE derivationOEL derivationOEB / OHC bandingRequest basket0
Substance information

Drug class, mechanism of action and general use cases

Drug class

Peripheral opioid antidiarrhoeal; mu-opioid receptor agonist

Mechanism of action

Activates opioid receptors in the intestinal wall, reducing propulsive peristalsis and prolonging intestinal transit time, which increases fluid and electrolyte absorption. It is commonly combined with atropine to discourage misuse.

General use cases

  • Adjunctive treatment of acute nonspecific diarrhoea in adults and children aged 13 years and older under the US product label, with fluid and electrolyte replacement as needed; not for bloody diarrhoea, invasive enteritis or toxin-mediated diarrhoea without evaluation

For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.

Assessment scope

Project-specific PDE/ADE and OEL/OEB support

Scope is agreed for the exact substance form, intended use, exposure route, workplace context and available toxicological evidence.

  • PDE/ADE: critical effects, point of departure and justified adjustment factors.
  • OEL: inhalation hazards, exposure duration and workplace conditions.
  • OEB/OHC: evidence-based banding where requested; a band is not a numerical OEL.
  • Report: scientific rationale, source data, assumptions, uncertainties and limitations.
Assessment scope

PDE/ADE and OEL/OEB assessment

ReguSight provides project-specific support for Diphenoxylate PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Diphenoxylate Permitted Daily Exposure (PDE) report (the Diphenoxylate PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Diphenoxylate Occupational Exposure Limit (OEL) report (the Diphenoxylate OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.